RedHill Biopharma Ltd.
RedHill Biopharma Ltd. RDHL Peers
See (RDHL) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RDHL | $2.02 | -6.91% | 5M | -0.01 | -$302.63 | N/A |
| ZTS | $153.45 | +1.49% | 68.4B | 27.57 | $5.57 | +1.27% |
| TAK | $14.74 | +1.31% | 46.6B | 64.13 | $0.23 | +3.99% |
| HLN | $9.75 | +1.04% | 43.8B | 23.19 | $0.42 | +1.72% |
| TEVA | $16.58 | +1.78% | 19B | -14.42 | -$1.15 | N/A |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| NBIX | $133.66 | +0.69% | 13.2B | 45.31 | $2.95 | N/A |
| RDY | $14.60 | +1.32% | 12.2B | 18.54 | $0.79 | +0.65% |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| VTRS | $9.37 | +1.41% | 11B | -2.95 | -$3.18 | +5.13% |
Stock Comparison
RDHL vs ZTS Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ZTS has a market cap of 68.4B. Regarding current trading prices, RDHL is priced at $2.02, while ZTS trades at $153.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ZTS's P/E ratio is 27.57. In terms of profitability, RDHL's ROE is +3.58%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, RDHL is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TAK Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TAK has a market cap of 46.6B. Regarding current trading prices, RDHL is priced at $2.02, while TAK trades at $14.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TAK's P/E ratio is 64.13. In terms of profitability, RDHL's ROE is +3.58%, compared to TAK's ROE of +0.04%. Regarding short-term risk, RDHL is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs HLN Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, HLN has a market cap of 43.8B. Regarding current trading prices, RDHL is priced at $2.02, while HLN trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas HLN's P/E ratio is 23.19. In terms of profitability, RDHL's ROE is +3.58%, compared to HLN's ROE of +0.09%. Regarding short-term risk, RDHL is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TEVA Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TEVA has a market cap of 19B. Regarding current trading prices, RDHL is priced at $2.02, while TEVA trades at $16.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TEVA's P/E ratio is -14.42. In terms of profitability, RDHL's ROE is +3.58%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, RDHL is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ITCI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, RDHL is priced at $2.02, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ITCI's P/E ratio is -180.64. In terms of profitability, RDHL's ROE is +3.58%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, RDHL is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs NBIX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, NBIX has a market cap of 13.2B. Regarding current trading prices, RDHL is priced at $2.02, while NBIX trades at $133.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas NBIX's P/E ratio is 45.31. In terms of profitability, RDHL's ROE is +3.58%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, RDHL is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs RDY Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, RDY has a market cap of 12.2B. Regarding current trading prices, RDHL is priced at $2.02, while RDY trades at $14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas RDY's P/E ratio is 18.54. In terms of profitability, RDHL's ROE is +3.58%, compared to RDY's ROE of +0.18%. Regarding short-term risk, RDHL is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs CTLT Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, RDHL is priced at $2.02, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas CTLT's P/E ratio is -27.84. In terms of profitability, RDHL's ROE is +3.58%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, RDHL is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs VTRS Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, VTRS has a market cap of 11B. Regarding current trading prices, RDHL is priced at $2.02, while VTRS trades at $9.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas VTRS's P/E ratio is -2.95. In terms of profitability, RDHL's ROE is +3.58%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, RDHL is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ELAN Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ELAN has a market cap of 7.5B. Regarding current trading prices, RDHL is priced at $2.02, while ELAN trades at $15.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ELAN's P/E ratio is 20.05. In terms of profitability, RDHL's ROE is +3.58%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, RDHL is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs RGC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, RGC has a market cap of 7.3B. Regarding current trading prices, RDHL is priced at $2.02, while RGC trades at $14.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas RGC's P/E ratio is -1479.00. In terms of profitability, RDHL's ROE is +3.58%, compared to RGC's ROE of -0.50%. Regarding short-term risk, RDHL is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs LNTH Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, LNTH has a market cap of 5.1B. Regarding current trading prices, RDHL is priced at $2.02, while LNTH trades at $73.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas LNTH's P/E ratio is 20.89. In terms of profitability, RDHL's ROE is +3.58%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, RDHL is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs PRGO Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, PRGO has a market cap of 3.9B. Regarding current trading prices, RDHL is priced at $2.02, while PRGO trades at $28.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas PRGO's P/E ratio is -23.43. In terms of profitability, RDHL's ROE is +3.58%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, RDHL is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs AMRX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, AMRX has a market cap of 3.8B. Regarding current trading prices, RDHL is priced at $2.02, while AMRX trades at $8.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas AMRX's P/E ratio is -201.75. In terms of profitability, RDHL's ROE is +3.58%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, RDHL is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs HCM Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, HCM has a market cap of 3.1B. Regarding current trading prices, RDHL is priced at $2.02, while HCM trades at $17.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas HCM's P/E ratio is 87.85. In terms of profitability, RDHL's ROE is +3.58%, compared to HCM's ROE of +0.05%. Regarding short-term risk, RDHL is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ALVOW Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ALVOW has a market cap of 2.8B. Regarding current trading prices, RDHL is priced at $2.02, while ALVOW trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ALVOW's P/E ratio is N/A. In terms of profitability, RDHL's ROE is +3.58%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, RDHL is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs ALVO Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ALVO has a market cap of 2.8B. Regarding current trading prices, RDHL is priced at $2.02, while ALVO trades at $9.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ALVO's P/E ratio is 24.76. In terms of profitability, RDHL's ROE is +3.58%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, RDHL is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs BHC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, BHC has a market cap of 2.5B. Regarding current trading prices, RDHL is priced at $2.02, while BHC trades at $6.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas BHC's P/E ratio is -55.42. In terms of profitability, RDHL's ROE is +3.58%, compared to BHC's ROE of +0.05%. Regarding short-term risk, RDHL is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs DCPH Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, RDHL is priced at $2.02, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas DCPH's P/E ratio is -11.58. In terms of profitability, RDHL's ROE is +3.58%, compared to DCPH's ROE of -0.28%. Regarding short-term risk, RDHL is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs INDV Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, INDV has a market cap of 2.1B. Regarding current trading prices, RDHL is priced at $2.02, while INDV trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas INDV's P/E ratio is -339.00. In terms of profitability, RDHL's ROE is +3.58%, compared to INDV's ROE of -0.01%. Regarding short-term risk, RDHL is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs BGM Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, BGM has a market cap of 2B. Regarding current trading prices, RDHL is priced at $2.02, while BGM trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas BGM's P/E ratio is -49.65. In terms of profitability, RDHL's ROE is +3.58%, compared to BGM's ROE of -0.03%. Regarding short-term risk, RDHL is more volatile compared to BGM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs EMBCV Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, RDHL is priced at $2.02, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas EMBCV's P/E ratio is N/A. In terms of profitability, RDHL's ROE is +3.58%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, RDHL is more volatile compared to EMBCV. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SUPN Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SUPN has a market cap of 1.8B. Regarding current trading prices, RDHL is priced at $2.02, while SUPN trades at $32.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SUPN's P/E ratio is 29.70. In terms of profitability, RDHL's ROE is +3.58%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, RDHL is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TARO Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, RDHL is priced at $2.02, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TARO's P/E ratio is 30.05. In terms of profitability, RDHL's ROE is +3.58%, compared to TARO's ROE of +0.02%. Regarding short-term risk, RDHL is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ANIP Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ANIP has a market cap of 1.4B. Regarding current trading prices, RDHL is priced at $2.02, while ANIP trades at $66.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ANIP's P/E ratio is -56.69. In terms of profitability, RDHL's ROE is +3.58%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, RDHL is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs DVAX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, DVAX has a market cap of 1.4B. Regarding current trading prices, RDHL is priced at $2.02, while DVAX trades at $11.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas DVAX's P/E ratio is -22.69. In terms of profitability, RDHL's ROE is +3.58%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, RDHL is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs EVO Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, EVO has a market cap of 1.4B. Regarding current trading prices, RDHL is priced at $2.02, while EVO trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas EVO's P/E ratio is -5.62. In terms of profitability, RDHL's ROE is +3.58%, compared to EVO's ROE of -0.22%. Regarding short-term risk, RDHL is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs HROW Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, HROW has a market cap of 1.4B. Regarding current trading prices, RDHL is priced at $2.02, while HROW trades at $36.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas HROW's P/E ratio is -60.57. In terms of profitability, RDHL's ROE is +3.58%, compared to HROW's ROE of -0.36%. Regarding short-term risk, RDHL is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs FLXN Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, FLXN has a market cap of 1.3B. Regarding current trading prices, RDHL is priced at $2.02, while FLXN trades at $25.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas FLXN's P/E ratio is N/A. In terms of profitability, RDHL's ROE is +3.58%, compared to FLXN's ROE of +6.19%. Regarding short-term risk, RDHL is more volatile compared to FLXN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs PAHC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, PAHC has a market cap of 1.2B. Regarding current trading prices, RDHL is priced at $2.02, while PAHC trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas PAHC's P/E ratio is 38.19. In terms of profitability, RDHL's ROE is +3.58%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, RDHL is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs AVDL Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, AVDL has a market cap of 1.1B. Regarding current trading prices, RDHL is priced at $2.02, while AVDL trades at $11.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas AVDL's P/E ratio is -42.58. In terms of profitability, RDHL's ROE is +3.58%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, RDHL is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs AMPH Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, AMPH has a market cap of 1.1B. Regarding current trading prices, RDHL is priced at $2.02, while AMPH trades at $22.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas AMPH's P/E ratio is 8.20. In terms of profitability, RDHL's ROE is +3.58%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, RDHL is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs COLL Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, COLL has a market cap of 1B. Regarding current trading prices, RDHL is priced at $2.02, while COLL trades at $32.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas COLL's P/E ratio is 26.57. In terms of profitability, RDHL's ROE is +3.58%, compared to COLL's ROE of +0.19%. Regarding short-term risk, RDHL is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs PCRX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, PCRX has a market cap of 1B. Regarding current trading prices, RDHL is priced at $2.02, while PCRX trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas PCRX's P/E ratio is -9.93. In terms of profitability, RDHL's ROE is +3.58%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, RDHL is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs PETQ Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, RDHL is priced at $2.02, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas PETQ's P/E ratio is 83.73. In terms of profitability, RDHL's ROE is +3.58%, compared to PETQ's ROE of +0.05%. Regarding short-term risk, RDHL is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs CRON Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, CRON has a market cap of 805.5M. Regarding current trading prices, RDHL is priced at $2.02, while CRON trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas CRON's P/E ratio is 14.93. In terms of profitability, RDHL's ROE is +3.58%, compared to CRON's ROE of +0.05%. Regarding short-term risk, RDHL is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TLRY Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TLRY has a market cap of 764.2M. Regarding current trading prices, RDHL is priced at $2.02, while TLRY trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TLRY's P/E ratio is -0.67. In terms of profitability, RDHL's ROE is +3.58%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, RDHL is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs EMBC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, EMBC has a market cap of 679.7M. Regarding current trading prices, RDHL is priced at $2.02, while EMBC trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas EMBC's P/E ratio is 13.07. In terms of profitability, RDHL's ROE is +3.58%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, RDHL is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ORGO Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ORGO has a market cap of 631.7M. Regarding current trading prices, RDHL is priced at $2.02, while ORGO trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ORGO's P/E ratio is -31.13. In terms of profitability, RDHL's ROE is +3.58%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, RDHL is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs EOLS Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, EOLS has a market cap of 617.7M. Regarding current trading prices, RDHL is priced at $2.02, while EOLS trades at $9.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas EOLS's P/E ratio is -10.76. In terms of profitability, RDHL's ROE is +3.58%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, RDHL is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs BDSI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, RDHL is priced at $2.02, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas BDSI's P/E ratio is 6.82. In terms of profitability, RDHL's ROE is +3.58%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, RDHL is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SIGA Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SIGA has a market cap of 511.5M. Regarding current trading prices, RDHL is priced at $2.02, while SIGA trades at $7.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SIGA's P/E ratio is 10.69. In terms of profitability, RDHL's ROE is +3.58%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, RDHL is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs KMDA Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, KMDA has a market cap of 454.9M. Regarding current trading prices, RDHL is priced at $2.02, while KMDA trades at $7.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas KMDA's P/E ratio is 28.25. In terms of profitability, RDHL's ROE is +3.58%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, RDHL is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs AQST Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, AQST has a market cap of 423.1M. Regarding current trading prices, RDHL is priced at $2.02, while AQST trades at $4.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas AQST's P/E ratio is -7.34. In terms of profitability, RDHL's ROE is +3.58%, compared to AQST's ROE of +1.07%. Regarding short-term risk, RDHL is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs EBS Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, EBS has a market cap of 415.2M. Regarding current trading prices, RDHL is priced at $2.02, while EBS trades at $7.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas EBS's P/E ratio is -2.97. In terms of profitability, RDHL's ROE is +3.58%, compared to EBS's ROE of -0.27%. Regarding short-term risk, RDHL is more volatile compared to EBS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SNDL Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SNDL has a market cap of 411.7M. Regarding current trading prices, RDHL is priced at $2.02, while SNDL trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SNDL's P/E ratio is -5.33. In terms of profitability, RDHL's ROE is +3.58%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, RDHL is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ALIM Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, RDHL is priced at $2.02, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ALIM's P/E ratio is 5.28. In terms of profitability, RDHL's ROE is +3.58%, compared to ALIM's ROE of -0.32%. Regarding short-term risk, RDHL is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs LFCR Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, LFCR has a market cap of 278.8M. Regarding current trading prices, RDHL is priced at $2.02, while LFCR trades at $7.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas LFCR's P/E ratio is -5.12. In terms of profitability, RDHL's ROE is +3.58%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, RDHL is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ACB Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ACB has a market cap of 274.5M. Regarding current trading prices, RDHL is priced at $2.02, while ACB trades at $4.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ACB's P/E ratio is 22.18. In terms of profitability, RDHL's ROE is +3.58%, compared to ACB's ROE of +0.00%. Regarding short-term risk, RDHL is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ZYBT Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ZYBT has a market cap of 273.9M. Regarding current trading prices, RDHL is priced at $2.02, while ZYBT trades at $5.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ZYBT's P/E ratio is 192.67. In terms of profitability, RDHL's ROE is +3.58%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, RDHL is more volatile compared to ZYBT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TKNO Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TKNO has a market cap of 272.5M. Regarding current trading prices, RDHL is priced at $2.02, while TKNO trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TKNO's P/E ratio is -11.09. In terms of profitability, RDHL's ROE is +3.58%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, RDHL is less volatile compared to TKNO. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs LNDC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, RDHL is priced at $2.02, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas LNDC's P/E ratio is -4.04. In terms of profitability, RDHL's ROE is +3.58%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, RDHL is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ESPR Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ESPR has a market cap of 263.6M. Regarding current trading prices, RDHL is priced at $2.02, while ESPR trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ESPR's P/E ratio is -1.56. In terms of profitability, RDHL's ROE is +3.58%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, RDHL is more volatile compared to ESPR. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs CGC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, CGC has a market cap of 243M. Regarding current trading prices, RDHL is priced at $2.02, while CGC trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas CGC's P/E ratio is -0.29. In terms of profitability, RDHL's ROE is +3.58%, compared to CGC's ROE of -1.13%. Regarding short-term risk, RDHL is more volatile compared to CGC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TYHT Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, RDHL is priced at $2.02, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TYHT's P/E ratio is -1.61. In terms of profitability, RDHL's ROE is +3.58%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, RDHL is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs OGI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, OGI has a market cap of 207.5M. Regarding current trading prices, RDHL is priced at $2.02, while OGI trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas OGI's P/E ratio is 11.92. In terms of profitability, RDHL's ROE is +3.58%, compared to OGI's ROE of +0.05%. Regarding short-term risk, RDHL is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SXTC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SXTC has a market cap of 196.1M. Regarding current trading prices, RDHL is priced at $2.02, while SXTC trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SXTC's P/E ratio is 0.01. In terms of profitability, RDHL's ROE is +3.58%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, RDHL is more volatile compared to SXTC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs REPH Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, RDHL is priced at $2.02, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas REPH's P/E ratio is -8.04. In terms of profitability, RDHL's ROE is +3.58%, compared to REPH's ROE of -0.22%. Regarding short-term risk, RDHL is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs BIOA Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, BIOA has a market cap of 173.9M. Regarding current trading prices, RDHL is priced at $2.02, while BIOA trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas BIOA's P/E ratio is -2.45. In terms of profitability, RDHL's ROE is +3.58%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, RDHL is more volatile compared to BIOA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs DERM Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, DERM has a market cap of 172.2M. Regarding current trading prices, RDHL is priced at $2.02, while DERM trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas DERM's P/E ratio is -19.97. In terms of profitability, RDHL's ROE is +3.58%, compared to DERM's ROE of -0.52%. Regarding short-term risk, RDHL is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs THTX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, THTX has a market cap of 145.1M. Regarding current trading prices, RDHL is priced at $2.02, while THTX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas THTX's P/E ratio is -16.61. In terms of profitability, RDHL's ROE is +3.58%, compared to THTX's ROE of +0.38%. Regarding short-term risk, RDHL is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs IRWD Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, IRWD has a market cap of 140.3M. Regarding current trading prices, RDHL is priced at $2.02, while IRWD trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas IRWD's P/E ratio is -4.56. In terms of profitability, RDHL's ROE is +3.58%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, RDHL is more volatile compared to IRWD. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs CRDL Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, CRDL has a market cap of 119M. Regarding current trading prices, RDHL is priced at $2.02, while CRDL trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas CRDL's P/E ratio is -4.24. In terms of profitability, RDHL's ROE is +3.58%, compared to CRDL's ROE of -2.10%. Regarding short-term risk, RDHL is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SCTL Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, RDHL is priced at $2.02, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SCTL's P/E ratio is -7.86. In terms of profitability, RDHL's ROE is +3.58%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, RDHL is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs PROC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, PROC has a market cap of 114M. Regarding current trading prices, RDHL is priced at $2.02, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas PROC's P/E ratio is 1.53. In terms of profitability, RDHL's ROE is +3.58%, compared to PROC's ROE of -2.22%. Regarding short-term risk, RDHL is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs OPTN Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, RDHL is priced at $2.02, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas OPTN's P/E ratio is -4.42. In terms of profitability, RDHL's ROE is +3.58%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, RDHL is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ZOM Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, RDHL is priced at $2.02, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ZOM's P/E ratio is -1.62. In terms of profitability, RDHL's ROE is +3.58%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, RDHL is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs IXHL Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, IXHL has a market cap of 94.6M. Regarding current trading prices, RDHL is priced at $2.02, while IXHL trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas IXHL's P/E ratio is -0.82. In terms of profitability, RDHL's ROE is +3.58%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, RDHL is less volatile compared to IXHL. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs GRVI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, RDHL is priced at $2.02, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas GRVI's P/E ratio is 26.05. In terms of profitability, RDHL's ROE is +3.58%, compared to GRVI's ROE of +0.28%. Regarding short-term risk, RDHL is more volatile compared to GRVI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs INCR Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, INCR has a market cap of 83.9M. Regarding current trading prices, RDHL is priced at $2.02, while INCR trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas INCR's P/E ratio is -3.50. In terms of profitability, RDHL's ROE is +3.58%, compared to INCR's ROE of -0.07%. Regarding short-term risk, RDHL is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs QNTM Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, QNTM has a market cap of 77.5M. Regarding current trading prices, RDHL is priced at $2.02, while QNTM trades at $22.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas QNTM's P/E ratio is -1.71. In terms of profitability, RDHL's ROE is +3.58%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, RDHL is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ASRT Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ASRT has a market cap of 73.8M. Regarding current trading prices, RDHL is priced at $2.02, while ASRT trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ASRT's P/E ratio is -2.41. In terms of profitability, RDHL's ROE is +3.58%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, RDHL is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ZYNE Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, RDHL is priced at $2.02, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, RDHL's ROE is +3.58%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, RDHL is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SSIC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, RDHL is priced at $2.02, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SSIC's P/E ratio is 11.93. In terms of profitability, RDHL's ROE is +3.58%, compared to SSIC's ROE of +0.09%. Regarding short-term risk, RDHL is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs VLNS Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, RDHL is priced at $2.02, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas VLNS's P/E ratio is -1.03. In terms of profitability, RDHL's ROE is +3.58%, compared to VLNS's ROE of N/A. Regarding short-term risk, RDHL is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs CPIX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, CPIX has a market cap of 53.3M. Regarding current trading prices, RDHL is priced at $2.02, while CPIX trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas CPIX's P/E ratio is -14.83. In terms of profitability, RDHL's ROE is +3.58%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, RDHL is more volatile compared to CPIX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs JUPW Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, RDHL is priced at $2.02, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas JUPW's P/E ratio is -2.41. In terms of profitability, RDHL's ROE is +3.58%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, RDHL is more volatile compared to JUPW. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs EGRX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, EGRX has a market cap of 40.8M. Regarding current trading prices, RDHL is priced at $2.02, while EGRX trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas EGRX's P/E ratio is 3.71. In terms of profitability, RDHL's ROE is +3.58%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, RDHL is less volatile compared to EGRX. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs QLI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, RDHL is priced at $2.02, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas QLI's P/E ratio is -4.92. In terms of profitability, RDHL's ROE is +3.58%, compared to QLI's ROE of -0.16%. Regarding short-term risk, RDHL is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs RMTI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, RMTI has a market cap of 38.3M. Regarding current trading prices, RDHL is priced at $2.02, while RMTI trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas RMTI's P/E ratio is -112.00. In terms of profitability, RDHL's ROE is +3.58%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, RDHL is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs KALA Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, KALA has a market cap of 36.5M. Regarding current trading prices, RDHL is priced at $2.02, while KALA trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas KALA's P/E ratio is -0.77. In terms of profitability, RDHL's ROE is +3.58%, compared to KALA's ROE of -3.69%. Regarding short-term risk, RDHL is more volatile compared to KALA. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs HEXO Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, RDHL is priced at $2.02, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas HEXO's P/E ratio is -0.26. In terms of profitability, RDHL's ROE is +3.58%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, RDHL is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SCYX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SCYX has a market cap of 28.6M. Regarding current trading prices, RDHL is priced at $2.02, while SCYX trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SCYX's P/E ratio is -1.31. In terms of profitability, RDHL's ROE is +3.58%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, RDHL is more volatile compared to SCYX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs CYTH Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, RDHL is priced at $2.02, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas CYTH's P/E ratio is -0.80. In terms of profitability, RDHL's ROE is +3.58%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, RDHL is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs DRRX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, DRRX has a market cap of 18.4M. Regarding current trading prices, RDHL is priced at $2.02, while DRRX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas DRRX's P/E ratio is -1.24. In terms of profitability, RDHL's ROE is +3.58%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, RDHL is more volatile compared to DRRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs GELS Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, GELS has a market cap of 18.4M. Regarding current trading prices, RDHL is priced at $2.02, while GELS trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas GELS's P/E ratio is -5.23. In terms of profitability, RDHL's ROE is +3.58%, compared to GELS's ROE of -0.07%. Regarding short-term risk, RDHL is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs PRPH Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, PRPH has a market cap of 18.1M. Regarding current trading prices, RDHL is priced at $2.02, while PRPH trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas PRPH's P/E ratio is -0.20. In terms of profitability, RDHL's ROE is +3.58%, compared to PRPH's ROE of -1.65%. Regarding short-term risk, RDHL is less volatile compared to PRPH. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs AYTU Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, AYTU has a market cap of 16.2M. Regarding current trading prices, RDHL is priced at $2.02, while AYTU trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas AYTU's P/E ratio is -1.77. In terms of profitability, RDHL's ROE is +3.58%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, RDHL is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs ACRX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, RDHL is priced at $2.02, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas ACRX's P/E ratio is -0.31. In terms of profitability, RDHL's ROE is +3.58%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, RDHL is more volatile compared to ACRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs COSM Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, COSM has a market cap of 14.3M. Regarding current trading prices, RDHL is priced at $2.02, while COSM trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas COSM's P/E ratio is -0.45. In terms of profitability, RDHL's ROE is +3.58%, compared to COSM's ROE of -0.51%. Regarding short-term risk, RDHL is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TXMD Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TXMD has a market cap of 13.9M. Regarding current trading prices, RDHL is priced at $2.02, while TXMD trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TXMD's P/E ratio is -6.32. In terms of profitability, RDHL's ROE is +3.58%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, RDHL is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs FLGC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, FLGC has a market cap of 13.8M. Regarding current trading prices, RDHL is priced at $2.02, while FLGC trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas FLGC's P/E ratio is -0.64. In terms of profitability, RDHL's ROE is +3.58%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, RDHL is more volatile compared to FLGC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs BFRI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, BFRI has a market cap of 11M. Regarding current trading prices, RDHL is priced at $2.02, while BFRI trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas BFRI's P/E ratio is -1.34. In terms of profitability, RDHL's ROE is +3.58%, compared to BFRI's ROE of -2.16%. Regarding short-term risk, RDHL is less volatile compared to BFRI. This indicates potentially lower risk in terms of short-term price fluctuations for RDHL.
RDHL vs AGRX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, RDHL is priced at $2.02, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas AGRX's P/E ratio is -0.89. In terms of profitability, RDHL's ROE is +3.58%, compared to AGRX's ROE of +0.93%. Regarding short-term risk, RDHL is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs IMCC Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, IMCC has a market cap of 9.3M. Regarding current trading prices, RDHL is priced at $2.02, while IMCC trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas IMCC's P/E ratio is -2.19. In terms of profitability, RDHL's ROE is +3.58%, compared to IMCC's ROE of -0.79%. Regarding short-term risk, RDHL is more volatile compared to IMCC. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs TLPH Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, TLPH has a market cap of 8.9M. Regarding current trading prices, RDHL is priced at $2.02, while TLPH trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas TLPH's P/E ratio is -0.99. In terms of profitability, RDHL's ROE is +3.58%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, RDHL is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs YCBD Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, YCBD has a market cap of 8.4M. Regarding current trading prices, RDHL is priced at $2.02, while YCBD trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas YCBD's P/E ratio is 0.01. In terms of profitability, RDHL's ROE is +3.58%, compared to YCBD's ROE of -0.01%. Regarding short-term risk, RDHL is more volatile compared to YCBD. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs NLTX Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, RDHL is priced at $2.02, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas NLTX's P/E ratio is -0.28. In terms of profitability, RDHL's ROE is +3.58%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, RDHL is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.
RDHL vs SISI Comparison
RDHL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDHL stands at 5M. In comparison, SISI has a market cap of 8.1M. Regarding current trading prices, RDHL is priced at $2.02, while SISI trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDHL currently has a P/E ratio of -0.01, whereas SISI's P/E ratio is N/A. In terms of profitability, RDHL's ROE is +3.58%, compared to SISI's ROE of -1.41%. Regarding short-term risk, RDHL is more volatile compared to SISI. This indicates potentially higher risk in terms of short-term price fluctuations for RDHL.